Related Experiment Videos
The gray zone
Clinical Laboratory Management Review : Official Publication of the Clinical Laboratory Management Association
|June 6, 1998
Summary
Laboratory results often fall into a "gray zone," using terms like equivocal or indeterminate, leading to interpretation challenges for clinicians and laboratorians. This ambiguity necessitates careful examination of its root causes and clinical implications.
Area of Science:
- Laboratory Medicine
- Clinical Pathology
Background:
- Laboratory results are expected to be definitive, yet often present as equivocal or indeterminate.
- Terms like equivocal (uncertain significance) and indeterminate (uncertain) highlight ambiguity in diagnostic reporting.
Purpose of the Study:
- To examine the root causes of the "gray zone" in laboratory interpretation.
- To illustrate how this ambiguity impacts clinical decision-making with examples.
Main Methods:
- Analysis of the definitions and implications of "equivocal" and "indeterminate" results.
- Review of clinical scenarios where laboratory data exhibits overlapping distributions.
Main Results:
- The "gray zone" arises from overlapping data distributions, contrasting with clinicians' desire for binary results.
- Ambiguous results, including those using jargon like ASCUS (atypical squamous cells of undetermined significance) or AGUS (atypical glandular cells of undetermined significance), create interpretive flexibility.
Conclusions:
- The "gray zone" is an inherent aspect of laboratory interpretation due to data characteristics.
- Understanding the origins of this ambiguity is crucial for both laboratorians and clinicians to navigate result interpretation effectively.